If We Could Turn Back Time: Danazol Preserves Telomere Length in Patients With Telomere Dysfunction
article
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Danazol treatment was found to preserve telomere length in patients diagnosed with telomere dysfunction, suggesting a potential therapeutic benefit for this condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (7)
- Danazol Treatment for Telomere Diseases via openalex
- Haematological recovery in dyskeratosis congenita patients treated with danazol via openalex
- doi:10.1111/bjh.12748 via openalex
- doi:10.1001/archpedi.1959.02070020295002 via openalex
- doi:10.3324/haematol.2015.129239 via openalex
- doi:10.1182/blood-2008-09-178871 via openalex
- doi:10.1038/nrg3246 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T10:46:08.476163+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK